MEGAN SANFORD: Open Payments
NPI 1073002515 · DECATUR, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$815 in 43 payments from 15 companies in 2025. Trend: 2023 $1,033 · 2024 $1,143 · 2025 $815
Food & beverage: $815
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $382 |
| Dexcom, Inc. | 4 | $73 |
| PFIZER INC. | 3 | $54 |
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| Lilly USA, LLC | 2 | $37 |
| Phathom Pharmaceuticals, Inc. | 2 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $26 |
| Janssen Biotech, Inc. | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $20 |
Products named: Wegovy, Ozempic, Dexcom G6 Transmitter, NURTEC ODT, BREZTRI, Kerendia, VOQUEZNA, CAPLYTA.
Industry payments across AL — which companies pay providers there.
